Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-07-07

FDA Approved: NARATRIPTAN — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved Naratriptan as an original ANDA for Hikma Pharmaceuticals USA Inc., authorizing a generic naratriptan product for the acute treatment of migrai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naratriptan (Naratriptan)

Snippet

ORIG AP for NARATRIPTAN (NARATRIPTAN)